Changes in insulin resistance after ileoduodenoplasty performing
DOI:
https://doi.org/10.11603/2414-4533.2023.3.14147Keywords:
insulin resistance, surgery, ileoduodenoplasty, diabetes mellitus, obesity, c-peptide, glucose, insulinAbstract
The aim of the work: to analyze own experience of IR changes in the course of performing metabolic correction in original way of ileac shift by stomach with duodenum exclusion from food passage.
Materials and Methods. Insulin resistance (IR) was studied in 15 patients with body mass index (BMI) within 20.3–58.3 kg/m2. Surgery consists of ileoduodenoplasty (IDP) performing by the way of duodenal and ileac transection and ileac shift by stomach with duodenum exclusion from food passage. In all patients fasting blood glucose, insulin and c-peptide levels were measured before surgery and 7–21 days by surgery.
According to blood level of insulin and c-peptide before surgery all cases may be differentiated into three groups.
Results and Discussion. Three weeks after surgery only in four patients of group 1 insulin content was on the upper level of norm or slightly higher of it while became, respectively, 59.1 %, and 32.8 %, and 42.2 %, and 34.7 % from preoperative indication. In two patients of group 2 insulin level falls into the range of norm, while in one it left slightly higher of those and, respectively, became 49.7 %, 34.7 %, and 21.0 % from those of pre-operation. Three patients (group 3) with insulin level withing normal range while c-peptide level was higher than range of norm.
It is not understandable at the time why c-peptide level at three weeks after surgery changes differently in all groups.
In all cases IR, which was regarded as higher than normal insulin or c-peptide level, disappear within three weeks after surgery.
Obtained data elucidate the difference in the IR origin. It is of interest the similar level of insulin in IR despite different concentration of c-peptide.
Also, it is of interest elevation of c-peptide level after surgery while IR disappear. Reasons of such reaction need further research.
References
Valerio Ceriani, Ferdinando Pinna, Antonio Galantino, Ahmed S. Zakaria, Roberto Manfrini, Antonio E. Pontiroli, and Franco Folli (2022). Biliopancreatic Diversion (BPD), Long Common Limb Revisional Biliopancreatic Diversion (BPD + LCL–R), Roux-en-Y Gastric Bypass [RYGB] and Sleeve Gastrectomy (SG) mediate differential quantitative changes in body weight and qualitative modifications in body composition: a 5-year study Acta Diabetol., 59(1), 39-48. Published online 2021 Aug 8. doi: 10.1007/s00592-021-01777-9 PMCID: PMC8758656 PMID: 34453598
Clare J Lee, Cynthia L Sears, Nisa Maruthur (2020). Gut microbiome and its role in obesity and insulin resistance. Review. Ann N Y Acad. Sci., 1461 (1), 37-52. DOI: 10.1111/nyas.14107. Epub 2019 May 14. PMID: 31087391 DOI: 10.1111/nyas.14107 DOI: https://doi.org/10.1111/nyas.14107
Gluvic Zoran, Zaric Bozidarka, Resanovic Ivana, Obradovic Milan, Mitrovic Aleksandar, Radak Djordje and Isenovic R. Esma (2017). Link between Metabolic Syndrome and Insulin Resistance. Current Vascular Pharmacology, 15 (1). https://dx.doi.org/10.2174/1570161114666161007164510 DOI: https://doi.org/10.2174/1570161114666161007164510
Lydia-Ann Harris, Brandon D. Kayser, Consuelo Cefalo, Luca Marini, Jeramie D. Watrous, Jeffrey Ding, Mohit Jain, Jeffrey G. McDonald, Bonne M. Thompson, Elisa Fabbrini, J. Christopher Eagon, Bruce W. Patterson, Bettina Mittendorfer, Geltrude Mingrone, and Samuel Klein Biliopancreatic diversion induces greater metabolic improvement than Roux-en-Y gastric bypass. Published in final edited form as: Cell Metab. 2019 Nov 5; 30(5): 855–864.e3. Published online 2019 Oct 3. DOI: 10.1016/j.cmet.2019.09.002 PMCID: PMC6876863 NIHMSID: NIHMS1543472 PMID: 31588013
Farnaz Fouladi, Amanda E. Brooks, Anthony A. Fodor, Ian M. Carroll, Emily C. Bulik-Sullivan, Matthew C.B. Tsilimigras, Michael Sioda, Kristine J. Steffen, Farnaz Fouladi (2019). The Role of the Gut Microbiota in Sustained Weight Loss Following Roux-en-Y Gastric Bypass Surgery. Obesity Surgery 29, Issue 4, 1259-1267 DOI: https://doi.org/10.1007/s11695-018-03653-y
Sandra Aparecida Dos Reis, Maria do Carmo Gouveia Peluzio, Josefina Bressan (2018). The use of antimicrobials as adjuvant therapy for the treatment of obesity and insulin resistance: Effects and associated mechanisms. Diabetes Metab Res Rev., 34, e3014. https://doi.org/10.1002/dmrr.3014 DOI: https://doi.org/10.1002/dmrr.3014
Napoleão, A., Fernandes, L., Miranda, C., Marum, A.P. (2021). Effects of Calorie Restriction on Health Span and Insulin Resistance: Classic Calorie Restriction Diet vs. Ketosis-Inducing Diet. Nutrients, 13, 1302. https://doi.org/10.3390/nu13041302 DOI: https://doi.org/10.3390/nu13041302
Josianne, C.H.B.M., Luijten, Guusje Vugts, Grard A.P. (2019). Nieuwenhuijzen, Misha D. P. Luyer. The Importance of the Microbiome in Bariatric Surgery: a Systematic Review. Obesity Surgery . 29, Issue 7, 2338-2349. DOI: https://doi.org/10.1007/s11695-019-03863-y
Lopez-Nava G., Negi A., Bautista-Castaño I., Rubio M.A. & Asokkumar R. (2020). Gut and Metabolic Hormones Changes After Endoscopic Sleeve Gastroplasty (ESG) Vs. Laparoscopic Sleeve Gastrectomy (LSG). Obesity Surgery 30, 2642-2651. https://doi.org/10.1007/s11695-020-04541-0 DOI: https://doi.org/10.1007/s11695-020-04541-0
Lidia Castagneto Gissey, James Casella Mariolo, Geltrude Mingrone, Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission. Peptides, 100, 2018, 114-122, ISSN 0196-9781, https://doi.org/10.1016/j.peptides.2017.12.010. DOI: https://doi.org/10.1016/j.peptides.2017.12.010
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 S. E. PODPRYATOV, S. S. PODPRIATOV, O. V. IVANKO, V. P. KORCHAK, O. V. LEVYTSKA, I. V. SATSYUK
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
